Genome sequencing and analysis of BCG vaccine strains.

BACKGROUND: Although the Bacillus Calmette-Guérin (BCG) vaccine against tuberculosis (TB) has been available for more than 75 years, one third of the world's population is still infected with Mycobacterium tuberculosis and approximately 2 million people die of TB every year. To reduce this imme...

Full description

Bibliographic Details
Main Authors: Wen Zhang, Yuanyuan Zhang, Huajun Zheng, Yuanlong Pan, Haican Liu, Pengcheng Du, Li Wan, Jun Liu, Baoli Zhu, Guoping Zhao, Chen Chen, Kanglin Wan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3747166?pdf=render
id doaj-2b73cb31304148eab91fc468081d7737
record_format Article
spelling doaj-2b73cb31304148eab91fc468081d77372020-11-24T21:50:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e7124310.1371/journal.pone.0071243Genome sequencing and analysis of BCG vaccine strains.Wen ZhangYuanyuan ZhangHuajun ZhengYuanlong PanHaican LiuPengcheng DuLi WanJun LiuBaoli ZhuGuoping ZhaoChen ChenKanglin WanBACKGROUND: Although the Bacillus Calmette-Guérin (BCG) vaccine against tuberculosis (TB) has been available for more than 75 years, one third of the world's population is still infected with Mycobacterium tuberculosis and approximately 2 million people die of TB every year. To reduce this immense TB burden, a clearer understanding of the functional genes underlying the action of BCG and the development of new vaccines are urgently needed. METHODS AND FINDINGS: Comparative genomic analysis of 19 M. tuberculosis complex strains showed that BCG strains underwent repeated human manipulation, had higher region of deletion rates than those of natural M. tuberculosis strains, and lost several essential components such as T-cell epitopes. A total of 188 BCG strain T-cell epitopes were lost to various degrees. The non-virulent BCG Tokyo strain, which has the largest number of T-cell epitopes (359), lost 124. Here we propose that BCG strain protection variability results from different epitopes. This study is the first to present BCG as a model organism for genetics research. BCG strains have a very well-documented history and now detailed genome information. Genome comparison revealed the selection process of BCG strains under human manipulation (1908-1966). CONCLUSIONS: Our results revealed the cause of BCG vaccine strain protection variability at the genome level and supported the hypothesis that the restoration of lost BCG Tokyo epitopes is a useful future vaccine development strategy. Furthermore, these detailed BCG vaccine genome investigation results will be useful in microbial genetics, microbial engineering and other research fields.http://europepmc.org/articles/PMC3747166?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Wen Zhang
Yuanyuan Zhang
Huajun Zheng
Yuanlong Pan
Haican Liu
Pengcheng Du
Li Wan
Jun Liu
Baoli Zhu
Guoping Zhao
Chen Chen
Kanglin Wan
spellingShingle Wen Zhang
Yuanyuan Zhang
Huajun Zheng
Yuanlong Pan
Haican Liu
Pengcheng Du
Li Wan
Jun Liu
Baoli Zhu
Guoping Zhao
Chen Chen
Kanglin Wan
Genome sequencing and analysis of BCG vaccine strains.
PLoS ONE
author_facet Wen Zhang
Yuanyuan Zhang
Huajun Zheng
Yuanlong Pan
Haican Liu
Pengcheng Du
Li Wan
Jun Liu
Baoli Zhu
Guoping Zhao
Chen Chen
Kanglin Wan
author_sort Wen Zhang
title Genome sequencing and analysis of BCG vaccine strains.
title_short Genome sequencing and analysis of BCG vaccine strains.
title_full Genome sequencing and analysis of BCG vaccine strains.
title_fullStr Genome sequencing and analysis of BCG vaccine strains.
title_full_unstemmed Genome sequencing and analysis of BCG vaccine strains.
title_sort genome sequencing and analysis of bcg vaccine strains.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Although the Bacillus Calmette-Guérin (BCG) vaccine against tuberculosis (TB) has been available for more than 75 years, one third of the world's population is still infected with Mycobacterium tuberculosis and approximately 2 million people die of TB every year. To reduce this immense TB burden, a clearer understanding of the functional genes underlying the action of BCG and the development of new vaccines are urgently needed. METHODS AND FINDINGS: Comparative genomic analysis of 19 M. tuberculosis complex strains showed that BCG strains underwent repeated human manipulation, had higher region of deletion rates than those of natural M. tuberculosis strains, and lost several essential components such as T-cell epitopes. A total of 188 BCG strain T-cell epitopes were lost to various degrees. The non-virulent BCG Tokyo strain, which has the largest number of T-cell epitopes (359), lost 124. Here we propose that BCG strain protection variability results from different epitopes. This study is the first to present BCG as a model organism for genetics research. BCG strains have a very well-documented history and now detailed genome information. Genome comparison revealed the selection process of BCG strains under human manipulation (1908-1966). CONCLUSIONS: Our results revealed the cause of BCG vaccine strain protection variability at the genome level and supported the hypothesis that the restoration of lost BCG Tokyo epitopes is a useful future vaccine development strategy. Furthermore, these detailed BCG vaccine genome investigation results will be useful in microbial genetics, microbial engineering and other research fields.
url http://europepmc.org/articles/PMC3747166?pdf=render
work_keys_str_mv AT wenzhang genomesequencingandanalysisofbcgvaccinestrains
AT yuanyuanzhang genomesequencingandanalysisofbcgvaccinestrains
AT huajunzheng genomesequencingandanalysisofbcgvaccinestrains
AT yuanlongpan genomesequencingandanalysisofbcgvaccinestrains
AT haicanliu genomesequencingandanalysisofbcgvaccinestrains
AT pengchengdu genomesequencingandanalysisofbcgvaccinestrains
AT liwan genomesequencingandanalysisofbcgvaccinestrains
AT junliu genomesequencingandanalysisofbcgvaccinestrains
AT baolizhu genomesequencingandanalysisofbcgvaccinestrains
AT guopingzhao genomesequencingandanalysisofbcgvaccinestrains
AT chenchen genomesequencingandanalysisofbcgvaccinestrains
AT kanglinwan genomesequencingandanalysisofbcgvaccinestrains
_version_ 1725884074320461824